The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model

Overview of attention for article published in Frontiers in immunology, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 51,550 followers.

The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model https://t.co/Syo3uVzI53 https://t.co/xxGIxrXuFD

19 Nov 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet bl…

19 Nov 2022

Reply Repost Favourite

New Research: The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model: We assessed the murine Stimulator of Interferon Genes (STING) agonist,… https://t.co/

19 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.